
### [MONDO:0001187](http://purl.obolibrary.org/obo/MONDO_0001187)
**Label:** urinary bladder cancer

**Subclasses:** [MONDO:0004986](http://purl.obolibrary.org/obo/MONDO_0004986) (bladder carcinoma (disease)), 

**Corr. equiv. classes:** [OMIM:109800](http://purl.obolibrary.org/obo/OMIM_109800), 

**Class expressions from DL-Learner:**

- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0002250](http://purl.obolibrary.org/obo/HP_0002250) (Abnormality of the large intestine))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0002242](http://purl.obolibrary.org/obo/HP_0002242) (Abnormality of the intestine))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0000078](http://purl.obolibrary.org/obo/HP_0000078) (Abnormality of the genital system))) 100.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma))) 100.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology))) 100.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology))) 100.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast))) 100.00%



### [MONDO:0001187](http://purl.obolibrary.org/obo/MONDO_0001187)
**Label:** urinary bladder cancer

**Subclasses:** [MONDO:0004986](http://purl.obolibrary.org/obo/MONDO_0004986) (bladder carcinoma (disease)), 

**Corr. equiv. classes:** [OMIM:109800](http://purl.obolibrary.org/obo/OMIM_109800), 

**Class expressions from DL-Learner:**

- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0002250](http://purl.obolibrary.org/obo/HP_0002250) (Abnormality of the large intestine))) 100.00%
- [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0002242](http://purl.obolibrary.org/obo/HP_0002242) (Abnormality of the intestine))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast))) 100.00%
- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0000078](http://purl.obolibrary.org/obo/HP_0000078) (Abnormality of the genital system))) 100.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma))) 100.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology))) 100.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology))) 100.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0006740](http://purl.obolibrary.org/obo/HP_0006740) (Transitional cell carcinoma of the bladder) and (not ([HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast))) 100.00%


